Yu gɛt lupus? If na so, yu dɔktɔ go dɔn tɔk to yu bɔt wan vaysin we dɛn kɔl Anifrolumab. Dis na nyu ɛn advans drɔg, so yu kin gɛt bɔku kwɛstyɔn bɔt am. Na nɔmal tin fɔ tink bɔt tin dɛm lɛk, "Dis go mɛn di sik kɔmplit wan?", "Ɛni sayd ɛfɛkt de?". Nɔ wɔri, tide wi go tɔk bɔt dis drɔg na wan rili simpul we we yu go ɔndastand.
Wetin na Anifrolumab (SAPHNELO) rili?
Fɔ tɔk am simpul wan, Anifrolumab na spɛshal vaysin we dɛn kin yuz fɔ mɛn lupus. i de pan wan klas dεm we dεn kכl `monoclonal antibodies.` Tink bכt wi bכdi in difεns sistεm (imyun sistεm) lεk sojaman. Insay sik lɛk lupus, dɛn sojaman ya kin kray smɔl ɛn bigin fɔ atak wi yon gud sɛl dɛn.
Dis drɔg we dɛn kɔl Anifrolumab, tan lɛk kɔmando we sabi du am. I de go stret to di pɔynt ɛn tek kɔntrol pan wan patikyula pat pan di imyun sistɛm we nɔ de wok fayn. Dis kin ɛp fɔ kɔntrol di damej ɛn di sayn dɛm we lupus kin kam wit.
Di impɔtant tin na dat Anifrolumab nɔto mɛrɛsin fɔ lupus. Bɔt dɛn kin yuz am togɛda wit ɔda lupus mɛrɛsin fɔ ɛp fɔ kɔntrol di sik.
Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu tek dis mɛrɛsin
Bifo yu bigin dis tritmɛnt, i rili impɔtant fɔ tɔk to yu dɔktɔ kɔmplit wan. Yu dɔktɔ fɔ no bɔt dɛn tin ya:
- If yu gɛt kansa ɔ yu dɔn gɛt am bifo.
- If yu gɛt ɛni infekshɔn naw, mɔ di vayral infɛkshɔn lɛk chikinpoks ɛn hεpi, yu fɔ tɛl yu dɔktɔ.
- If yu jɔs dɔn gɛt ɛni vaysin, ɔ yu de plan fɔ gɛt wan tumara bambay.
- If yu gɛt alɛji fɔ dis mɛrɛsin (Anifrolumab) ɔ ɛni ɔda mɛrɛsin, it, ɔ day.
- If yu gɛt bɛlɛ, ɔ yu de tray fɔ gɛt bɛlɛ.
- If yu na mama we de gi pikin in bɛlɛ.
I rili impɔtant fɔ yu sef fɔ gi dis infɔmeshɔn to di dɔktɔ. So tɛl am ɔltin ɛn nɔ ayd ɛnitin.
Aw fɔ yuz di mɛrɛsin?
Anifrolumab nɔto mɛrɛsin we yu kin kɛr go na os. Na wan infushɔn we dɛn kin put insay di bɛlɛ . Dis min se dɛn kin gi di mɛrɛsin insay yu vein frɔm bɔtul, we fiba salin. Dɛn kin du dis tritmɛnt na ɔspitul ɔ klinik ɔnda di sɔpɔtishɔn fɔ di mɛdikal wokman dɛn we tren.
I rili impɔtant fɔ mek yu gɛt yu tritmɛnt di de dɛn we yu dɔn sɛtul. If fɔ ɛni rizin yu nɔ ebul fɔ atɛnd di de we yu dɔn sɛtul, kɔl yu dɔktɔ ɔ klinik wantɛm wantɛm ɛn mek dɛn no.
Wetin a go du if a tek bɔku mɛrɛsin?
Dɛn kin gi dis na ɔspitul say so di chans fɔ mek dis apin rili smɔl. Bɔt if yu tink se yu dɔn tek di mɛrɛsin tumɔs, tɛl di dɔktɔ dɛn wantɛm wantɛm. Ɔda we de fɔ kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital . If ɛnitin apin, go na di Imejɛnsi Tritmɛnt Yunit (ETU) we de nia yu .
Prɔblɛm kin de wit ɔda mɛrɛsin dɛn? (Intarakshɔn dɛn)
Yes, sɔm mɛrɛsin dɛn kin intarakt wit Anifrolumab. So, yu fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek, lɛk di mɛrɛsin dɛn we dɛn kin gi yu, di mɛrɛsin dɛn we dɛn kin bay na kɔt, ɔyl dɛn, ɛn ivin vaytamɛn dɛn.
| Drugs wae kin intarakt wit Anifrolumab | |
|---|---|
| Nɔ tek wit dɛn tin ya atɔl: | |
| Layf vayrɔs vaysin dɛn | Fɔ ɛgzampul: MMR, chikinpoks vaysin, ɛn ɔda tin dɛn Aks yu dɔktɔ bɔt dis. |
| Intarakshɔn kin apin wit dɛn tin ya (infɔm di dɔktɔ): | |
| Ɔda bayolojikal drɔgs dɛn | Eks: adalimumab, ɛtanɛsɛpt, infliximab |
| Ɔda Mɔnoklɔnal antibodi dɛn | Fɔ ɛgzampul: belimumab, rituximab |
| Sayklɔfosfamid | Dis na drɔg bak we de kɔntrol di imyuniti. |
Wetin na di tin dɛm we yu fɔ tek tɛm wit we yu de tek mɛrɛsin?
Risk fɔ gɛt di sik
Bikɔs dis mɛrɛsin de stɔp yu imyun sistɛm te to sɔm mak, yu kin gɛt infɛkshɔn smɔl. So, if yu gɛt sɔm sayn dɛn lɛk fiva, kol, trot we de at, bɔdi we de at, ɔ we yu de bɔn we yu de pis, nɔ fɔ tek mɛrɛsin fɔ yusɛf ɛn tɔk to yu dɔktɔ wantɛm wantɛm. Dɔn bak, tray fɔ de fa frɔm pipul dɛn we sik.
Risk fɔ gɛt kansa
Dɔktɔ dɛn kin tink bak bɔt di risk fɔ gɛt sɔm kayn kansa we dɛn de tek dɛn mɛrɛsin ya. Nɔr nid fɔ wɔri bɔt dis, bɔt i fayn fɔ tɔk to yu dɔktɔ bɔt dis ɛn ɔndastand klia wan di prɔblɛm dɛn we kin apin.
Us sayd ɛfɛkt dɛn kin apin?
Lɛk ɛni mɛrɛsin, Anifrolumab kin mek sɔm pipul dɛn gɛt sayd ɛfɛkt. Dɛn kin sheb dɛn tin ya mɔ to tu kategori.
| Sayd ɛfɛkt dɛn we yu fɔ ripɔt to yu dɔktɔ wantɛm wantɛm | |
|---|---|
| Alɛji Riakshɔn dɛn | Skin rash, it, ayv, swel na di fes, lip, ɔ tong. |
| Sayn dɛn we de sho se pɔsin gɛt di sik | Fiva, kol, kɔf, trot we de at, urinary tract infection. |
| I nɔ kin izi fɔ yu fɔ blo | If yu de gɛt prɔblɛm fɔ blo ɔ yu fil se yu chɛst tayt. |
| Lɔw blɔd prɛshɔn | Diziz, fɔdɔm, ɛn taya we nɔ kɔmɔn, mɔ we yu de tek di mɛrɛsin. |
| Tɛl yu dɔktɔ if i kɔntinyu fɔ de ɔ i de mɔna yu. | |
| Ed de at | (Ed de at) |
| Vɔmit | (Vɔmit) |
| Fɔ vɔmit | (We yu de vɔmit) . |
Mɛsej we dɛn kin kɛr go na os
- Anifrolumab nɔto mɛrɛsin fɔ lupus, bɔt na tritmɛnt we rili fayn fɔ kɔntrol di sik dɛn.
- Bifo yu tek dis mɛrɛsin, tɛl yu dɔktɔ yu kɔmplit mɛdikal istri (inklud ɔda mɛrɛsin dɛn we yu de tek).
- Dis na injɛkshɔn we dɛn kin gi insay di bɛlɛ na ɔspitul. I impɔtant fɔ gɛt tritmɛnt di de dɛn we dɛn dɔn plan fɔ du.
- Tek tɛm bad bad wan pan di sayn dɛm we de sho se yu gɛt di sik lɛk fiva ɛn kɔf we yu de trit yu. If yu gɛt ɛni wan pan dɛn tin ya, tɛl yu dɔktɔ wantɛm wantɛm.
- Nɔ fred fɔ tɔk to yu dɔktɔ bɔt ɛni sayd ɛfɛkt we yu gɛt, ilɛksɛf na smɔl tin.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt